High T2-weighted signal intensity is associated with elevated troponin T in hypertrophic cardiomyopathy

Dh Frank Gommans1, G Etienne Cramer1, Jeannette Bakker2

  • 1Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Insights

Areas of high signal intensity (HighT2) on cardiovascular magnetic resonance (CMR) indicate active injury in hypertrophic cardiomyopathy (HCM). HighT2 is strongly associated with elevated cardiac troponin, supporting its role as a marker of myocyte injury.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Biomarkers

Background:

  • Areas of high signal intensity (HighT2) on T2-weighted cardiovascular magnetic resonance (CMR) are observed in hypertrophic cardiomyopathy (HCM).
  • HighT2 is hypothesized to represent active tissue injury in HCM patients.

Purpose of the Study:

  • To investigate the association between HighT2 on CMR and cardiac troponin levels in HCM patients.
  • To evaluate HighT2 as an indicator of active myocyte injury in hypertrophic cardiomyopathy.

Main Methods:

  • Outpatient HCM patients underwent 1.5T CMR including T2-weighted, cine, and late gadolinium enhancement (LGE) imaging.
  • Left ventricular (LV) function, mass, and LGE extent were assessed.
  • Highly sensitive cardiac troponin T (hs-cTnT) was measured, with elevated levels defined as ≥14 ng/L and detectable levels as >3 ng/L.

Main Results:

  • HighT2 was present in 28% of HCM patients.
  • Elevated hs-cTnT was significantly more common in patients with HighT2 (54%) compared to those without (14%) (p<0.001).
  • The extent of HighT2 correlated with hs-cTnT concentrations (Spearman's ρ: 0.42, p<0.001).

Conclusions:

  • HighT2 is observed in a quarter of HCM patients and is associated with elevated hs-cTnT.
  • The strong association and high negative predictive value of undetectable hs-cTnT for HighT2 support its role in indicating recent myocyte injury.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
618
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
427
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
716
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
903